Mother and child (MDMG) Stock Forecast
AI forecast: MDMG
Di AI publish a target price fi di next trading day, di end of di week and di end of di month. Di change is measure from di latest price. Dis dem is statistical estimates, not investment advice.
Price over the last 6 months
Premium shows di AI price targets fi 1 day, 1 week an 1 month fi dis an every odda stock.
Unlock Premium🔒 Track record fi di forecast
Di track record fi di forecast — every past forecast next to di actual close — is part of Premium.
Unlock PremiumBout This Company
Mater and Ditya is one of the leaders of the Russian private healthcare market. Founded in 2006 by obstetrician-gynecologist Mark Kurtser, the company now holds a leading position in Russia in the field of women’s and children’s health. The company’s assets include 11 high-tech hospitals, 44 clinics, and one medical university. The medical facilities specialize in a broad range of healthcare services, providing care in reproductive medicine, women’s health, and pediatrics, as well as in the treatment of socially significant diseases, including oncology and cardiology. In 2022, the company ranked second in Forbes’ “Top 20 Medical Companies – 2022” ranking, with revenue of RUB 25 billion.
